Celularity revenue was $48.20M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2024) ending on Sep 30, 2024 was $9.3M, down 23.2% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, CELU annual revenue was $22.8M, with 26.7% growth year-over-year.
CELU past revenue growth
How has CELU's revenue growth performed historically?
On Invalid Date, Celularity (NASDAQ: CELU) reported Q3 2024 revenue of $9.30 million up 145.54% year over year. In the same quarter last year, Celularity's revenue was $3.79 million.
What was Celularity's revenue in 2023?
Celularity's annual revenue for the twelve months ending Dec 31, 2023 was $22.77 million, a 26.68% increase year over year.
How much does Celularity make in a day?
Based on Celularity annual revenue for the past four years, CELU makes an average of $52,300.68 per day.
What was Celularity's annual revenue growth in the past year?
As of Q2 2025, Celularity's revenue has grown 225.94% year over year. This is 271.75 percentage points lower than the US Biotechnology industry revenue growth rate of 497.69%. Celularity's revenue in the past year totaled $48.20 million.
How much does Celularity make in a year?
Celularity's revenue by year for the past four years is:
Celularity's revenue for the twelve months ending Dec 31, 2023 was $22.77 million, a 26.68% increase year over year.
Celularity's annual revenue for Dec 31, 2022 was $17.98 million, a 15.75% decrease from 2021.
Celularity's annual revenue for 2021 was $21.34 million, a 49.43% increase from 2020.
Celularity's annual revenue for 2020 was $14.28 million, a 32.48% decrease from 2019.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.